Volume 10 Issue 68
Published - 14:00 UTC 08:00 EST 8-Mar-2008 
Next Update - 14:00 UTC 08:00 EST 9-Mar-2008

Editor: Susan K. Boyer, RN
© RAmEx Ars Medica,Inc.
All rights reserved.

HONcode accreditation seal. We subscribe to the HONcode principles.
Verify here
.

   

 


Recent generic drug approvals

Each year, FDA approves scores of generic drugs that treat a variety of conditions and help consumers save money. more  

NIH receives gates foundation grant to investigate role of iron supplements in malaria

Do iron supplements worsen the course of malaria? Researchers aren't sure, and the uncertainty has jeopardized efforts to treat the debilitating effects of iron deficiency in parts of the world where malaria and other infectious diseases are common. more

Studying mutations in non-hodgkin lymphoma yields clues for potential new therapies

DNA mutations found in a type of non-Hodgkin lymphoma that has a poor prognosis has led researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and their colleagues to a better understanding of how the cancer develops and how it might be treated. The research findings appear in the March 6 2008, issue of Science. more  

FDA drug safety newsletter

This publication provides postmarketing information to healthcare professionals to enhance communication of new drug safety information, raise awareness of reported adverse events, and stimulate additional adverse event reporting. more

Ankylosing spondylitis genes found  

Work supported by the National Institute of Arthritis and Musculoskeletal Skin Diseases has led to the discovery of two genes responsible for ankylosing spondylitis (AS), an inflammatory and potentially disabling disease of the spine. more

MicroRNA molecule prevents skin cell proliferation 

Researchers supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases have discovered a molecule that keeps cells in the outer layers of skin from proliferating in mice. Their finding, to be published in the March 13 issue of Nature, could lead to a better understanding of skin cancer and open up new avenues of therapeutic research. more

Information for patients: What is metabolic syndrome?

Metabolic syndrome is the name for a group of risk factors linked to overweight and obesity that increase your chance for heart disease and other health problems such as diabetes and stroke. The term “metabolic” refers to the biochemical processes involved in the body’s normal functioning. Risk factors are behaviors or conditions that increase your chance of getting a disease. In this article, “heart disease” refers to coronary heart disease. more

© RAmEx Ars Medica,Inc. All rights reserved.

Information appearing on the Vidyya Medical News Service is not intended as a substitute for professional medical care. Seek professional medical help and follow your health care provider's advice.

Interested in subscribing to our daily e-mail newsletter? Send an email to Vidyya@Ramex.com with the word subscribe in the subject field.

Generic drugs cost about 20% to 70% less than their brand name counterparts. The Congressional Budget Office has reported that generic drugs save consumers an estimated $8 billion to $10 billion a year.